Who
Michael J.M. Hitchcock
Interim CEO
Company insider
Files Form 4 as: Interim CEO, Biomea Fusion.
In numbers
- Trades disclosed
- 11
- Buys
- 3
- Sells
- 0
- Bought
- $239K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 15 Apr 2021
- Last trade
- 1 Apr 2026
- Last filed
- 3 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Apr 2026filed 3 Apr 2026 | BMEA Biomea Fusionoption or derivative · Biotechnology | SEC FORM 4 Code A | —667,477 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | BMEA Biomea Fusionoption or derivative · Biotechnology | SEC FORM 4 Code A | —667,477 at $0.00 | filing |
| 2 Dec 2025filed 4 Dec 2025 | BMEA Biomea FusionBiotechnology | SEC FORM 4 Bought | $99K100,000 at $0.99 | filing |
| 11 Aug 2025filed 13 Aug 2025 | BMEA Biomea Fusionoption or derivative · Biotechnology | SEC FORM 4 Code A | —916,434 at $0.00 | filing |
| 26 Mar 2025filed 28 Mar 2025 | BMEA Biomea Fusionoption or derivative · Biotechnology | SEC FORM 4 Code A | —350,000 at $0.00 | filing |
| 30 Sep 2024filed 1 Oct 2024 | BMEA Biomea FusionBiotechnology | SEC FORM 4 Bought | $101K10,000 at $10.06 | filing |
| 12 Jun 2024filed 13 Jun 2024 | BMEA Biomea Fusionoption or derivative · Biotechnology | SEC FORM 4 Code A | —51,025 at $0.00 | filing |
| 14 Jun 2023filed 16 Jun 2023 | BMEA Biomea Fusionoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,989 at $0.00 | filing |
| 14 Nov 2022filed 16 Nov 2022 | BMEA Biomea FusionBiotechnology | SEC FORM 4 Bought | $40K5,000 at $7.93 | filing |
| 22 Jun 2022filed 24 Jun 2022 | BMEA Biomea Fusionoption or derivative · Biotechnology | SEC FORM 4 Code A | —23,867 at $0.00 | filing |
| 15 Apr 2021filed 19 Apr 2021 | BMEA Biomea Fusionoption or derivative · Biotechnology | SEC FORM 4 Code A | —28,911 at $0.00 | filing |
News
Biomea Fusion to Announce Phase I Results for BMF-650, Its Next-Generation Oral Small-Molecule GLP-1 Receptor AgonistBMEA · manilatimes.net · 12 Oct 2026
0 headlines in the last 90 days name Michael J.M. Hitchcock; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.